Literature DB >> 24126584

Outpatient antibiotic use in France between 2000 and 2010: after the nationwide campaign, it is time to focus on the elderly.

Adeline Bernier1, Elisabeth Delarocque-Astagneau, Caroline Ligier, Marie-Anne Vibet, Didier Guillemot, Laurence Watier.   

Abstract

Antibiotic overconsumption is the main force driving the emergence of multidrug-resistant bacterial strains. To promote better antibiotic use in France, a nationwide campaign has been run every year from October to March since 2002. In 2007, it was shown that winter outpatient antibiotic consumption had decreased by 26.5% compared to the 2000-2002 baseline period. Here, we quantified outpatient antibiotic use between 2000 and 2010 as a follow-up analysis of the nationwide campaign. Reimbursed outpatient antibiotic prescriptions were extracted from computerized French National Health Insurance databases. Entire series and age group and antibiotic class analyses were computed. Time series analyses used autoregressive moving-average models with exogenous variables and intervention functions. Two periods were considered: October to March "campaign" periods and April to September "warm" periods. Compared to the precampaign (2000-2002) baseline period, the numbers of weekly antibiotic prescriptions per 1,000 inhabitants during campaign periods decreased until winter 2006 to 2007 (-30% [95% confidence interval {CI}, -36.3 to -23.8%]; P < 0.001) and then stabilized except for individuals >60 years of age, for whom prescriptions reached the precampaign level. During the warm periods from April to September, no significant differences were estimated compared to the baseline level for the entire series, but seniors had an increasing trend that became significant as of 2005, reaching +21% (95% CI, +12.9 to +29.6%) in 2009 (P < 0.0001). These results highlight the need for a better understanding of antibiotic use by the elderly, requiring research with targeted and tailored public health actions for this population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24126584      PMCID: PMC3910776          DOI: 10.1128/AAC.01813-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Excessive antibiotic use for acute respiratory infections in the United States.

Authors:  R Gonzales; D C Malone; J H Maselli; M A Sande
Journal:  Clin Infect Dis       Date:  2001-08-21       Impact factor: 9.079

Review 2.  Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme.

Authors:  S Mölstad; M Erntell; H Hanberger; E Melander; C Norman; G Skoog; C Stålsby Lundborg; A Söderström; E Torell; O Cars
Journal:  Lancet Infect Dis       Date:  2008-02       Impact factor: 25.071

3.  Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC).

Authors:  H Goossens; S Coenen; M Costers; S De Corte; A De Sutter; B Gordts; L Laurier; Mj Struelens
Journal:  Euro Surveill       Date:  2008-11-13

4.  Box-Jenkins modelling in medical research.

Authors:  U Helfenstein
Journal:  Stat Methods Med Res       Date:  1996-03       Impact factor: 3.021

5.  Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.

Authors:  R Gonzales; J F Steiner; M A Sande
Journal:  JAMA       Date:  1997-09-17       Impact factor: 56.272

6.  Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.

Authors:  A C Nyquist; R Gonzales; J F Steiner; M A Sande
Journal:  JAMA       Date:  1998-03-18       Impact factor: 56.272

7.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

8.  Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007.

Authors:  Elifsu Sabuncu; Julie David; Claire Bernède-Bauduin; Sophie Pépin; Michel Leroy; Pierre-Yves Boëlle; Laurence Watier; Didier Guillemot
Journal:  PLoS Med       Date:  2009-06-02       Impact factor: 11.069

9.  Antimicrobial drug use and resistance in Europe.

Authors:  Nienke van de Sande-Bruinsma; Hajo Grundmann; Didier Verloo; Edine Tiemersma; Jos Monen; Herman Goossens; Matus Ferech
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

10.  Did media attention of the 2009 A(H1N1) influenza epidemic increase outpatient antibiotic use in France?: A time-series analysis.

Authors:  Adeline Bernier; Caroline Ligier; Didier Guillemot; Laurence Watier
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more
  12 in total

1.  Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control.

Authors:  Laura Temime; Lulla Opatowski; David Rm Smith
Journal:  Elife       Date:  2021-09-14       Impact factor: 8.140

2.  How to improve antibiotic awareness campaigns: findings of a WHO global survey.

Authors:  Benedikt Huttner; Mirko Saam; Lorenzo Moja; Karen Mah; Marc Sprenger; Stephan Harbarth; Nicola Magrini
Journal:  BMJ Glob Health       Date:  2019-05-09

3.  Marked increase in incidence for bloodstream infections due to Escherichia coli, a side effect of previous antibiotic therapy in the elderly.

Authors:  Nathalie L van der Mee-Marquet; Dominique S Blanc; Houssein Gbaguidi-Haore; Sandra Dos Santos Borges; Quentin Viboud; Xavier Bertrand; Roland Quentin
Journal:  Front Microbiol       Date:  2015-06-30       Impact factor: 5.640

4.  Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis.

Authors:  Anna Alari; Hélène Chaussade; Matthieu Domenech De Cellès; Lénaig Le Fouler; Emmanuelle Varon; Lulla Opatowski; Didier Guillemot; Laurence Watier
Journal:  BMC Med       Date:  2016-12-21       Impact factor: 8.775

Review 5.  Systematic review of public-targeted communication interventions to improve antibiotic use.

Authors:  Elizabeth Louise Anne Cross; Robert Tolfree; Ruth Kipping
Journal:  J Antimicrob Chemother       Date:  2017-04-01       Impact factor: 5.790

6.  Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map.

Authors:  Susan Rogers Van Katwyk; Jeremy M Grimshaw; Miriam Nkangu; Ranjana Nagi; Marc Mendelson; Monica Taljaard; Steven J Hoffman
Journal:  PLoS Med       Date:  2019-06-11       Impact factor: 11.069

7.  Outpatient antibiotic use in Dutch infants after 10-valent pneumococcal vaccine introduction: a time-series analysis.

Authors:  Alexandre C Fortanier; Roderick P Venekamp; Rebecca K Stellato; Elisabeth A M Sanders; Roger A M J Damoiseaux; Arno W Hoes; Anne M Schilder
Journal:  BMJ Open       Date:  2018-06-30       Impact factor: 2.692

8.  Antibiotics prescription and guidelines adherence in elderly: impact of the comorbidities.

Authors:  Anthony Dylis; Anne Sophie Boureau; Audrey Coutant; Eric Batard; François Javaudin; Gilles Berrut; Laure de Decker; Guillaume Chapelet
Journal:  BMC Geriatr       Date:  2019-10-29       Impact factor: 3.921

9.  Impact of national interventions to promote responsible antibiotic use: a systematic review.

Authors:  Jane Mingjie Lim; Shweta Rajkumar Singh; Minh Cam Duong; Helena Legido-Quigley; Li Yang Hsu; Clarence C Tam
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

Review 10.  Public target interventions to reduce the inappropriate use of medicines or medical procedures: a systematic review.

Authors:  Leesa Lin; Prima Alam; Elizabeth Fearon; James R Hargreaves
Journal:  Implement Sci       Date:  2020-10-20       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.